AAAAAA
Results:
1-18
|
Results: 18
Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations
Authors:
Timur, AA
Gurgey, A
Aktuglu, G
Kavakli, K
Canatan, D
Olek, K
Caglayan, SH
Citation: Aa. Timur et al., Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations, HAEMOPHILIA, 7(5), 2001, pp. 475-481
Authors:
Kavakli, K
Huseyinov, A
Coker, I
Aydinok, Y
Nisli, G
Citation: K. Kavakli et al., Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease, HAEMOPHILIA, 7(5), 2001, pp. 482-489
Authors:
Aydogdu, S
Memis, A
Kavakli, K
Balkan, C
Citation: S. Aydogdu et al., The pelvi-femoral incomplete bone bridge in a patient with mild haemophilia, HAEMOPHILIA, 7(2), 2001, pp. 224-226
Authors:
Kavakli, K
Nisli, G
Citation: K. Kavakli et G. Nisli, Circumcision, hemophilia, and being healthy in developing countries, PED HEM ONC, 18(6), 2001, pp. 419-420
Authors:
Kavakli, K
Aydinok, Y
Karapinar, D
Balkan, C
Citation: K. Kavakli et al., DDAVP treatment in children with haemophilia B, BR J HAEM, 114(3), 2001, pp. 733-734
Authors:
Kavakli, K
Kurugol, Z
Goksen, D
Nisli, G
Citation: K. Kavakli et al., Should hemophiliac patients be circumcised?, PED HEM ONC, 17(2), 2000, pp. 149-153
Authors:
Aksit, S
Vardar, F
Kantar, M
Kavakli, K
Yucel, G
Buyukinan, M
Citation: S. Aksit et al., Haemorrhagic shock and encephalopathy syndrome in four Turkish children, ACT PAEDIAT, 89(5), 2000, pp. 620-621
Authors:
Kurugol, Z
Vardar, F
Ozkinay, F
Kavakli, K
Ozkinay, C
Citation: Z. Kurugol et al., Lupus anticoagulant and protein S deficiency in otherwise healthy childrenwith acute varicella infection, ACT PAEDIAT, 89(10), 2000, pp. 1186-1189
Authors:
Avanoglu, A
Celik, A
Ulman, I
Ozcan, C
Kavakli, K
Nisli, G
Gokdemir, A
Citation: A. Avanoglu et al., Safer circumcision in patients with haemophilia: the use of fibrin glue for local haemostasis, BJU INT, 83(1), 1999, pp. 91-94
Authors:
Kavakli, K
Citation: K. Kavakli, Fibrin glue and clinical impact on haemophilia care, HAEMOPHILIA, 5(6), 1999, pp. 392-396
Authors:
EL-Maarri, O
Kavakli, K
Caglayan, SH
Citation: O. El-maarri et al., Intron 22 inversions in the Turkish haemophilia A patients: prevalence andhaplotype analysis, HAEMOPHILIA, 5(3), 1999, pp. 169-173
Authors:
Cetingul, N
Aydmok, Y
Kantar, M
Oniz, H
Kavakli, K
Yalman, O
Erermis, S
Celebisoy, N
Akyurekli, O
Oztop, S
Nisli, G
Citation: N. Cetingul et al., Neuropsychologic sequelae in the long-term survivors of childhood acute lymphoblastic leukemia, PED HEM ONC, 16(3), 1999, pp. 213-220
Authors:
Kavakli, K
Polat, A
Huseyinof, A
Nisli, G
Aydinok, Y
Citation: K. Kavakli et al., Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease, THROMB HAEM, 81(4), 1999, pp. 665-666
Authors:
Aydinok, Y
Coker, C
Kavakli, K
Polat, A
Nisli, G
Cetiner, N
Kantar, M
Cetingul, N
Citation: Y. Aydinok et al., Urinary zinc excretion and zinc status of patients with beta-thalassemia major, BIOL TR EL, 70(2), 1999, pp. 165-172
Authors:
Kavakli, K
Nisli, G
Kutukculer, N
Polat, A
Aydinok, Y
Oztop, S
Centingul, N
Citation: K. Kavakli et al., Long-term prophylaxis and immune parameters in haemophilia, J TROP PEDI, 45(2), 1999, pp. 122-123
Authors:
Kantar, M
Cetingul, N
Oniz, H
Aydinok, Y
Kavakli, K
Citation: M. Kantar et al., Skin toxicity after administration of low-dose cytarabine, MED PED ONC, 33(4), 1999, pp. 420-421
Authors:
Aydinok, Y
Nisli, G
Kavakli, K
Citation: Y. Aydinok et al., Alternate use of deferiprone and desferrioxamine in primary school children with thalassaemia major, BR J HAEM, 106(1), 1999, pp. 252-253
Authors:
Aydinok, Y
Nisli, G
Kavakli, K
Coker, C
Kantar, M
Cetingul, N
Citation: Y. Aydinok et al., Sequential use of deferiprone and desferrioxamine in primary school children with thalassaemia major in Turkey, ACT HAEMAT, 102(1), 1999, pp. 17-21
Risultati:
1-18
|